Comment from the CEO
Bentley’s entrepreneurial team has positioned us as the European market leader in covered stents substituting open surgery. We are propelled by the megatrend of an aging population that increasingly requires endovascular treatment of aortic and peripheral diseases. We are delighted to have Keensight Capital join us on our growth journey and support us in our go-to-market strategy in the US. We are also very pleased to have A.P. Møller Holding and Bonit Capital on board. It’s great to find this high esteem of the financial community for our innovation-driven business and the achievements of our committed employees. The continued strong position of the founders and management will secure our position as an independent player. The stage is set. I firmly believe that our success will continue for many years to come.
Sebastian Büchert, CEO
